¹ú±êÂ鶹ÊÓƵAPP

¹ú±êÂ鶹ÊÓƵAPP Dr. Newman Harris offers part one of a two-part series that outlines the latest ways to define and classify chronic pain as laid out in ICD-11. Understanding how pain informs impairment is an essential piece of our work, and this article provides additional clarit... Read More

In Read More

¹ú±êÂ鶹ÊÓƵAPP Sandeepan Basu provides an overview of the Fourth Universal Definition of Myocardial Infarction. This well-researched article delves into key aspects of the updated definition, explores its complexity, and presents potential implications for the life insurance ...

Read More

The life and health insurance customer journey can be an emotional experience. RGAX's Charlie Matthews believes that in digitizing that journey carriers should begin by identifying customers' wants, needs, and expectations and then work to create an experience that addr... Read More

Insurers seem to be chasing appearances, but sleek, web-based systems can mask a distressing reality: Underwriting technology underpinning the decision process is not attracting the same attention. ¹ú±êÂ鶹ÊÓƵAPP Bruce Bosco calls for a greater emphasis on automated underwrit...

Read More

In this issue, explore topics from chronic pain and myocardial infarction to applying behavioral economics to non-disclosure. 
Read More

The impact of genetic testing on the insurance industry will continue to be an important topic of actuarial research for some time as insurers address its effect on pricing and valuation. Insurance product development opportunities may also emerge to capitalize upon the... Read More

RGA has conducted a global survey of technology use in claims, spanning 107 companies. To learn more about ¹ú±êÂ鶹ÊÓƵAPP key findings, download the

Read More

Where is product development for insurance headed in Japan? RGA asked 30 major Japanese insurers in a comprehensive survey, and the company also conducted a complementary survey of approximately 4,800 policyholders of life products in Japan. The results were ill...

Read More

The wider implications of recent advances in genetics and genomics, including polygenic risk scores, need to be considered in the context of the protection industry. ¹ú±êÂ鶹ÊÓƵAPP Heather Lund and Richard Russell explore the topic in depth in the Journal of the Asso...

Read More

Similar to the protective value analysis RGA completed on other key data sources used in life insurance underwriting, such as motor vehicle records and prescription drug scoring, RGA’s goal was to understand the relationship of credit to mortality outcomes. Given credit... Read More

For more than half a century, ultrasound and Doppler have been the two main technologies used to administer screening and diagnostic tests during pregnancy. Explore these technologies with Dr. Elizabeth Gil Agular in Global Health Briefs. 

Read More

Discussing a medical condition with a stranger – such as a case manager – can be daunting. This is doubly difficult when it comes to feelings of depression, anxiety, and other mental health conditions.  Melinda Baxter of the ROSE^® Consu...

Read More

RGA kicks off a four-part series of articles on the topic of fraud in ON THE RISK, the Journal of The Academy of Life Underwriting. Featuring experts from insurance and other industries, the series will explore new ways fraud is being committed and share bes...

Read More

Life insurance remains a tough sell in MENA, but changes are afoot, creating opportunities for players able to adjust their strategies for business development. ¹ú±êÂ鶹ÊÓƵAPP Tamer Saher spoke to Read More

Around 800,000 people commit suicide every year1 – one person every 40 seconds. Suicide has a profound impact on family and friends that are left behind following the unexpected death of a loved one. Explore risk factors. Read More

This is especially true in the world of work, as we find that occupations and industries that existed for decades are now slowly falling away: think landline telephony in this era of smartphones, or VCRs and video rental stores in the age of Netflix and online streami...

Read More

Genomic medicine promises to change the way oncologists assess, treat, and follow patients with cancer. How will advances in targeted drug therapy, including immunotherapeutic agents, influence the mortality and morbidity of certain cancers? ¹ú±êÂ鶹ÊÓƵAPP Dr. Lisa Duckett sh...

Read More

The chronic respiratory condition asthma poses unique challenges when it appears in children. Elite Sales Processing Chief Underwriting Officer Dennis Gunderson shares what every underwriter should know about the causes, symptoms, treatment and mortality risk of juve...

Read More

Rapid medical advances, as well as growing volumes of health and mortality data, are transforming cancer risk assessment. ¹ú±êÂ鶹ÊÓƵAPP Neil Parkin explores our deepening understanding and insurance implications.   Read More